The lawsuit, titled Mazzarino v. ADMA Biologics, Inc., et al., claims that the company and its executives violated federal securities laws by failing to disclose critical information in offering documents. According to the complaint, the firm allegedly utilized channel stuffing to inflate revenue figures and failed to maintain adequate internal controls. Furthermore, the litigation highlights an undisclosed related-party transaction, asserting that these omissions rendered the company's public statements regarding its business operations materially false.

Legal firm Kahn Swick & Foti, LLC, led by former Louisiana Attorney General Charles C. Foti, Jr., is representing the class. Investors who suffered financial losses during the specified period are encouraged to contact Managing Partner Lewis Kahn to discuss their options. While the court deadline for requesting appointment as lead plaintiff is August 10, 2026, potential claimants should note that serving as a lead plaintiff is not a requirement to participate in any eventual recovery.